Growth Metrics

Canton Strategic Holdings (CNTN) Cash & Equivalents (2020 - 2026)

Canton Strategic Holdings posted quarterly Cash & Equivalents of $41.5 million for Q1 2026, up 3760.12% year-on-year from $1.1 million in Q1 2025, and up 143.84% on a QoQ basis from $17.0 million in Q4 2025.

Canton Strategic Holdings (CNTN) has 7 years of Cash & Equivalents data on file, last reported at $41.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 3760.12% year-over-year to $41.5 million; the trailing twelve-month figure through Mar 2026 stood at $41.5 million (up 3760.12% YoY), and the FY2025 full-year result was $17.0 million, up 378.53% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $41.5 million, up from $17.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $41.5 million in Q1 2026 and bottomed at $1.1 million in Q1 2025.
  • The 5-year median for Cash & Equivalents is $7.6 million (2022), against an average of $8.8 million.
  • The widest annual swing landed in 2022, when Cash & Equivalents surged 149361.29%; it then slumped 87.23% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $6.5 million in 2022, then soared by 67.96% to $10.9 million in 2023, then sank by 67.45% to $3.6 million in 2024, then surged by 378.53% to $17.0 million in 2025, then surged by 143.84% to $41.5 million in 2026.
  • The last three Cash & Equivalents figures came in at $41.5 million (Q1 2026), $17.0 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 1.91 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 32.30 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 61.46 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.71 Bn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn - 41.53 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 41.53 Mn
Dec 31, 2025 17.03 Mn
Sep 30, 2025 7.61 Mn
Jun 30, 2025 2.24 Mn
Mar 31, 2025 1.08 Mn
Dec 31, 2024 3.56 Mn
Sep 30, 2024 4.77 Mn
Jun 30, 2024 7.90 Mn
Mar 31, 2024 8.43 Mn
Dec 31, 2023 10.94 Mn
Sep 30, 2023 2.69 Mn
Jun 30, 2023 3.90 Mn
Mar 31, 2023 3.57 Mn
Dec 31, 2022 6.51 Mn
Sep 30, 2022 7.60 Mn
Jun 30, 2022 9.48 Mn
Mar 31, 2022 11.12 Mn
Dec 31, 2021 4,356.00
Sep 30, 2021 45,095.00
Jun 30, 2021 29,271.00
Mar 31, 2021 22,507.00
Dec 31, 2020 191,852.00